Skip to content

A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.

Finance and Financial Sector

119-s2529 — A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.. Sponsored by Sen. Husted, Jon [R-OH]. Introduced 2025-07-30. Senate bill. 119th Congress. Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

119-s2529 119th Congress Senate
XML Congress.gov
Sponsor
Sen. Husted, Jon [R-OH] (R), OH
Introduced
2025-07-30
Committees
Health, Education, Labor, and Pensions Committee
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

No roll-call vote data available for this bill.

Similar Bills

  • 116-hr4816 — CFTC Reauthorization Act of 2019 85% match 116th Congress
  • 116-hr2515 — Whistleblower Programs Improvement Act 64% match 116th Congress
  • 117-s3977 — SEC Whistleblower Reform Act of 2022 31% match 117th Congress
  • 117-hr5485 — Whistleblower Protection Reform Act of 2021 28% match 117th Congress
  • 116-hr6197 — Whistleblower Protection Reform Act of 2019 21% match 116th Congress
Investigate this bill → Beneficiary scoring, topic classification, and fiscal analysis